• Lead chelation
• Cardiovascular support
Serving Size: 1 Level Tablespoon (approx 11.5g)... %DV
Vitamin C (from ascorbic acid, calcium... 3000 mg... 5000%
and magnesium ascorbates)
Calcium (from calcium carbonate, ascorbate)... 545 mg... 55%
Magnesium (from magnesium carbonate, ascorbate)... 340 mg... 85%
L-Lysine... 3000 mg... †
L-Proline... 2000 mg... †
L-Taurine... 250 mg... †
Potassium (from potassium bicarbonate)... 99 mg... †
† Daily Value not established
What Is It?
TLC 3.0 represents a true orthomolecular formulation with testimonials from case reports that indicate amazing results. TLC 3.0 contains an unprecedented combination of nutrients to keep blood vessels strong based on the research of the late Dr. Linus Pauling (along with Dr. Matthias Rath), who made a connection between vitamin C and atherosclerosis. He discovered that guinea pigs, humans and primates are just about the only mammals that get atherosclerosis; coincidentally, these are also the only species that cannot synthesize their own vitamin C.
What Does It Do?
Primary Uses: TLC 3.0 is designed to preserve blood vessel health. High-dose vitamin C helps to produce collagen, which in turn heals, strengthens and protects the arteries, particularly against the potential danger posed by a circulating lipoprotein known as Lp(a). Lp(a) binds to the cellular matrix of injured blood vessels, rapidly delivering the cholesterol needed to regenerate the cell wall. Of course, this is how vascular function is compromised. Lysine and proline provide alternate binding sites for Lp(a), reducing its ability to attach to the blood vessels and allowing vitamin C to do the healing work. Taurine, magnesium, potassium and calcium are also essential for good muscle and nerve function in the heart.
Who Should Take It?
Those looking for a high-dose vitamin C formula, an electrolyte formula and those who have already suffered from various cardiovascular complications should consider supplementing with TLC 3.0. Athletes such as long distance runners can also benefit from TLC 3.0.
240 g powder
Stir 1 level tablespoon (approx. 11.5 g) into a glass of water or juice once daily, or as directed by a qualified health care practitioner.
CAUTION: Consult a health care practitioner prior to use if you are following a low protein diet or if you are pregnant or breastfeeding.
Boonmark NW, Lou XJ, Yang ZJ, Schwartz K, Zhang JL, Rubin EM, Lawn RM. Modification of apolipoprotein(a) lysine binding site reduces atherosclerosis in transgenic mice. J Clin Invest. 1997 Aug 1;100(3):558-64.
Lippi G, Guidi G. Lipoprotein(a): an emerging cardiovascular risk factor. Crit Rev Clin Lab Sci. 2003 Feb; 40(1): 1-42.
Price KD, Price CS, Reynolds RD. Hyperglycemia-induced latent scurvy and atherosclerosis: the scorbutic-metaplasia hypothesis. Med Hypotheses. 1996 Feb; 46(2): 119-29.
Rath M. and Pauling L. Immunological evidence for the accumulation of lipoprotein(a) in the atherosclerotic lesion of the hypoascorbemic guinea pig. PNAS. 87(23): 9388-90.Rath M, Pauling L. Hypothesis: lipoprotein(a) is a surrogate for ascorbate. PNAS. 1990 Aug; 87(16): 6204-7.
Rath M. Lipoprotein(a) reduction by ascorbate. J Orthomolec Med. 1992 Aug; 7(1): 81-2.
Rath M. Reducing the risk for cardiovascular disease with nutritional supplements. J Orthomolec Med.1995; 7(3): 153-62.
Trieu VN, Zioncheck TF, Lawn RM, McConathy WJ. Interaction of apolipoprotein(a) with apolipoprotein B-containing lipoproteins. J Biol Chem. 1991 Mar 25; 266(9): 5480-5.
Willis GC. The reversibility of atherosclerosis. CMAJ. 1957 Jul 15; 77(2): 106-9.
Disclaimer: This content is subject to change. The information is intended to inform and educate; it does not replace the medical evaluation, advice, diagnosis or treatment by a healthcare professional. www.nhpassist.com © 2014 NDAssist Inc. and/or its affiliates. All rights reserved.